|
|
|
|
07.15-08.00 |
Meet the Expert 5: Papillary thyroid
cancer management |
| |
|
CLYDE AUDITORIUM |
| |
|
Chair: I Szabolcz (Hungary) |
| |
|
I Hay (Rochester, USA) |
| |
|
|
| |
07.15-08.00 |
Meet the Expert 6: Adrenal carcinoma |
| |
|
Generously supported by HRA Pharma |
| |
|
LOMOND AUDITORIUM |
| |
|
Chair: M Terzolo (Orbassano, Italy) |
| |
|
M Reincke (Munich, Germany) |
| |
|
|
| |
07.15-08.00 |
Meet the Expert 7: Transgenic techniques |
| |
|
HALL 1 |
| |
|
Chair: I Robinson (London, UK) |
| |
|
M Poutanen (Turku, Finland) |
| |
|
|
| |
07.15-08.00 |
Meet the Expert 8: Pitfalls in signal
transduction research |
| |
|
FORTH ROOM |
| |
|
Chair: L Hunyady (Budapest, Hungary) |
| |
|
W Knepel (Göttingen, Germany) |
| |
|
|
| |
08.10-10.10 |
Symposium 5: Novel peptides in reproduction |
| |
|
Generously supported by AstraZeneca |
| |
|
CLYDE AUDITORIUM |
| |
|
Chairs: R Millar (Edinburgh, UK) & A
Milewicz (Wroclaw, Poland) |
S26 |
08.10 |
The
kisspeptin-GPR54 axis in reproduction |
| |
|
M Tena-Sempere (Cordoba, Spain) |
S27 |
08.40 |
Use
of recombinant leptin in women with hypothalamic amenorrhea |
| |
|
C Welt (Boston, USA) |
S28 |
09.10 |
A
genomic analysis of polypeptide ligands and their receptors: examples
of relaxin and LGR families |
| |
|
T Hsu (Stanford, USA) |
S29 |
09.40 |
Novel
recombinant gonadotropin molecules in human reproductive dysfunction |
| |
|
B Mannaerts (Oss, The Netherlands) |
| |
|
|
| |
08.10-10.10 |
Oral Communications 3: Clinical endocrinology |
| |
|
HALL 1 |
| |
|
Chairs: M Grussendorf (Stuttgart, Germany) & S
Lamberts (Rotterdam, The Netherlands) |
OC17 |
08.10 |
Copeptin,
a precursor of vasopressin, in critically ill patients - an observational
study |
| |
|
M Christ-Crain, N Morgenthaler, J Struck,
A Bergmann & B Mueller |
OC18 |
08.25 |
Endoscope-assisted
pituitary surgery for functioning and non-functioning pituitary
adenomas. The experience of the first 80 patients in a single centre |
| |
|
PL Hanson, SM Joshi, G Alusi, HI Sabin, WM
Drake & JP Monson |
OC19 |
08.40 |
Disease
remission in long term treated acromegalic patients after somatostatin
analogs withdrawal |
| |
|
C L Ronchi, V Varca, A Lania, M Arosio, A
Spada & P Beck-Peccoz |
OC20 |
08.55 |
A
European prospective real-life observational study of quality of
life in patients with acromegaly |
| |
|
SM Webb, A Colao, P Caron, M Carvalheiro,
E Ertürk, A Pokrajac-Simeunovic, J Schopohl, S Tsagarakis,
IV Pearson, X Badia, S Caglio & B Vincenzi |
OC21 |
09.10 |
Adjuvant
radiation therapy of the tumor bed prevents local recurrences in
adrenocortical carcinoma |
| |
|
M Fassnacht, S Hahner, B Polat, AC Koschker,
M Flentje & B Allolio |
OC22 |
09.25 |
Detection
of phaeochromocytoma: the emerging role of plasma metanephrines |
| |
|
RT Peaston, SG Ball, R Quinton, RA James,
S Pearce, TWJ Lennard & RDG Neely |
OC23 |
09.40 |
Improved
prognosis in midgut carcinoid patients by treating raised circulating
neurokinin A (NKA) |
| |
|
JES Ardill, BJ Johnston, GB Turner, A McGinty & DR
McCance |
OC24 |
09.55 |
Low
testosterone and atherogenic lipid profile in aging men |
| |
|
JI Mäkinen, A Perheentupa, K Irjala,
P Pöllänen, J Mäkinen, I Huhtaniemi & O Raitakari |
| |
|
|
| |
08.10-10.10 |
Symposium 6: Hot topics |
| |
|
LOMOND AUDITORIUM |
| |
|
Chairs: Pierre Bouloux (London, UK) & J
Köhrle (Berlin, Germany) |
| |
08.10 |
The obesity epidemic glutamate and umami regulation
of food intake |
| |
|
J Tresguerres (Madrid, Spain) |
| |
08.35 |
Transthyretin and neuropeptide processing |
| |
|
M Mendes Sousa (Porto, Portugal) |
| |
09.00 |
Tissue specific effects of a novel plant derived
SERM: 8-prenyl-naringenin |
| |
|
WD Schleuning (Berlin, Germany) |
| |
09.25 |
Genetic polymorphism redefine setpoints of the
pituitary thyroid axis |
| |
|
R Peeters (Rotterdam, The Netherlands) |
| |
09.50 |
Oligonucleotide microarrays and their applications
in thyroid cancer |
| |
|
B Jarzab (Gliwice, Poland) |
| |
|
|
| |
08.10-10.10 |
Symposium 7: Flies, worms and fish: use
in endocrine research |
| |
|
FORTH ROOM |
| |
|
Chair: K Docherty (Aberdeen, UK) |
S30 |
08.10 |
Long
live the worm:C. elgeans, insulin and aging |
| |
|
D Gems (London, UK) |
S31 |
08.40 |
Dietary
restriction and altered insulin/Igf1 signalling: conserved mechanisms
regulating lifespan in worms, flies and rodents |
| |
|
D Withers (London, UK) |
S32 |
09.10 |
Giant
flies and more: probing the functions and genetics of insulin signalling
in |
| |
|
Drosophila C Wilson (Oxford, UK) |
S33 |
09.40 |
Specifying
the cellular responses to IGF signalling by IGF binding proteins:
new lessons from the zebrafish model |
| |
|
C Duan (Ann Arbor, USA) |
| |
|
|
| |
10.10-10.40 |
COFFEE |
| |
|
HALL 3 |
| |
|
|
| |
10.40-11.25 |
Clinical Endocrinology Trust Visiting
Professor Lecture |
| |
|
CLYDE AUDITORIUM |
| |
|
Chair: L Rees (London, UK) |
S4 |
10.40 |
Understanding
the genetic control of puberty in the human |
| |
|
W Crowley (Boston, USA) |
| |
|
|
| |
11.35-12.20 |
Meet the Expert 5: Papillary thyroid
cancer management |
| |
|
CLYDE AUDITORIUM |
| |
|
Chair: I Szabolcz (Hungary) |
| |
|
I Hay (Rochester, USA) |
| |
|
|
| |
11.35-12.20 |
Meet the Expert 6: Adrenal carcinoma |
| |
|
LOMOND AUDITORIUM |
| |
|
Chair: M Terzolo (Orbassano, Italy) |
| |
|
M Reincke (Munich, Germany) |
| |
|
|
| |
11.35-12.20 |
Meet the Expert 7: Transgenic techniques |
| |
|
HALL 1 |
| |
|
Chair: I Robinson (London, UK) |
| |
|
M Poutanen (Turku, Finland) |
| |
|
|
| |
11.35-12.20 |
Meet the Expert 8: Pitfalls in signal
transduction research |
| |
|
FORTH ROOM |
| |
|
Chair: L Hunyady (Budapest, Hungary) |
| |
|
W Knepel (Göttingen, Germany) |
| |
|
|
| |
12.20-13.50 |
Shire Pharmaceuticals Satellite Symposium
PCOS - The cruel face of a complex disease |
| |
|
FORTH ROOM |
| |
|
|
| |
12.20-13.50 |
Pfizer Satellite Symposium 1 Young, middle-aged
and elderly patients with GHD: insights into age-related responses
to GH replacement |
| |
|
CLYDE AUDITORIUM |
| |
|
|
| |
13.50-14.00 |
Society for Endocrinology EGM |
| |
|
CLYDE AUDITORIUM |
| |
|
|
| |
14.00-14.45 |
British Thyroid Association AGM |
| |
|
ALSH ROOM |
| |
|
|
| |
13.50-14.50 |
POSTERS AND LUNCH |
| |
|
HALL 3 |
| |
|
|
| |
14.50-16.50 |
Symposium 8: Clinical lessons from novel
aspects of G protein-coupled receptors signalling |
| |
|
CLYDE AUDITORIUM |
| |
|
Chairs: A Spada (Milan, Italy) & A Breit
(Marburg, Germany) |
S34 |
14.50 |
How
the pattern of GPCR co-expression can regulate function |
| |
|
G Milligan (Glasgow, UK) |
S35 |
15.20 |
Alpha-
and beta-adrenoceptor dysfunction |
| |
|
L Hein (Würzburg, Germany) |
S36 |
15.50 |
Molecular
pathology of the FSH receptor |
| |
|
M Misrahi (Paris, France) |
S37 |
16.20 |
Therapeutic
implications from new aspects in V2 vasopressin receptor dysfunction |
| |
|
T Schöneberg (Leipzig, Germany) |
| |
|
|
| |
14.50-16.50 |
Clinical Management Workshop 3: Management
of Graves' ophthalmopathy |
| |
|
LOMOND AUDITORIUM |
| |
|
Chair: W Wiersinga (Amsterdam, The Netherlands) |
S81 |
14.50 |
Prevention
of thyroid eye disease |
| |
|
G Krassas (Thessaloniki, Greece) |
S82 |
15.20 |
Medical
treatment |
| |
|
C Marcocci (Pisa, Italy) |
S83 |
15.50 |
Alternative
immunomodulatory therapies for Graves' ophthalmopathy |
| |
|
J Banga (London, UK) |
S84 |
16.20 |
Ophthalmic
management of thyroid eye disease |
| |
|
G Rose (London, UK) |
| |
|
|
| |
14.50-16.50 |
Basic Workshop:In vivo imaging of signalling |
| |
|
HALL 1 |
| |
|
Chair: TBA |
S85 |
14.50 |
OPT:
a novel wholemount imaging technology for visualising gene and
protein expression |
| |
|
S Wedden (Edinburgh, UK) |
S86 |
15.30 |
A
mouse reporting on estrogen receptor (ER) transcriptional activity
to understand the complexities of female physiology in mammals |
| |
|
A Maggi (Milan, Italy) |
S87 |
16.10 |
Micro
PET-ing in mice |
| |
|
M Kreissl (Wuerzburg, Germany) |
| |
|
|
| |
14.50-16.50 |
Oral Communications 4: Diabetes and metabolism |
| |
|
FORTH ROOM |
| |
|
Chairs: R Corcoy (Barcelona, Spain) & H
Romijn (Leiden, The Netherlands) |
OC25 |
14.50 |
Cannabinoids
increase AMP-activated protein kinase (AMPK) enzyme activity in
the hypothalamus and heart via different signalling pathways -
studies in CB1 knockout animals |
| |
|
B Kola, M Christ-Crain, G Wittman, C Leontiou,
A Grossman, C Fekete & M Korbonits |
OC26 |
15.05 |
Neuropeptide
S is a novel peptide, which potently stimulates the hypothalamopituitary-
adrenal axis and inhibits food intake |
| |
|
KL Smith, M Patterson, WS Dhillo, SR Patel,
NM Semjonous, JV Gardiner, MA Ghatei & SR Bloom |
OC27 |
15.20 |
A
selective increase in adipose 11b-HSD1 expression in corticosterone-treated
POMC-null mice is associated with development of metabolic syndrome |
| |
|
ZM Michailidou, APC Coll, NMM Morton, CJ
Kenyon, S O'Rahilly, JR Seckl & KE Chapman |
OC28 |
15.35 |
11b-Hydroxysteroid
dehydrogenase type 1 oxoreductase activity is increased in patients
with alcoholic chronic liver disease: the key to the phenotype
of the alcoholic pseudo-Cushing's state? |
| |
|
A Ahmed, S Saksena, E Elias & PM Stewart |
OC29 |
15.50 |
A
choline deficient diet in mice prevents high fat diet-induced insulin
resistance in spite of more severe fatty liver disease |
| |
|
PJ Raubenheimer, MJ Nyirenda & BR Walker |
OC30 |
16.05 |
The
release of the adipocytokine visfatin is regulated by glucose and
insulin |
| |
|
DG Haider, G Schaller, S Kapiotis, C Maier,
A Luger & M Wolzt |
OC31 |
16.20 |
Comparative
analysis of the effects of dehydroepiandrosterone (DHEA) on white
and brown pre-adipocyte proliferation/differentiation |
| |
|
SPL Rice, E Wang, MF Scanlon, M Ludgate & DA
Rees |
OC32 |
16.35 |
The
in vitro effects of resistin on the innate immune signalling pathway
in isolated human subcutaneous adipocytes |
| |
|
CM Kusminski, NF da Silva, AL Harte, S Kumar & PG
McTernan |
| |
|
|
| |
16.50-17.30 |
TEA |
| |
|
HALL 3 |
| |
|
|
| |
17.30-18.15 |
Plenary 2 |
| |
|
CLYDE AUDITORIUM |
| |
|
Chair: B Ake Bengtsson (Sweden) |
S9 |
17.30 |
Statins
and rhabdomyolysis |
| |
|
M Law (London, UK) |
| |
|
|
| |
18.30-20.00 |
Pfizer Satellite Symposium 2 Clinical
management of acromegaly: applying 10 years of human experience
with pegvisomant |
| |
|
CLYDE AUDITORIUM |
| |
|
FREE EVENING |
